Home Biotechnology Cell Therapy Market Size, Top Share, Global Trends, Forecast to 2033

Cell Therapy Market Size, Share & Trends Analysis Report By Product (Media, Sera, and Reagents, Cell Engineering products, Cell Culture Vessels, Cell therapy Equipment, System and Software, Other Products), By Cell Type (T-Cells, Stem Cells, Other Cells), By Cell Process (Cell Processing, Cell Preservation, Distribution, and Handling, Process Monitoring and Quality Control), By End User (Biopharmaceutical and Biotechnology companies, CRO’s and CMO’s, Research Institutes & Cell Banks) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRBI55592DR
Author : Debashree Bora

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Cell Therapy Market Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Media, Sera, and Reagents
        1. By Value
      3. Cell Engineering products
        1. By Value
      4. Cell Culture Vessels
        1. By Value
      5. Cell therapy Equipment
        1. By Value
        2. Cell Processing Equipment
          1. Cell Processing Equipment By Value
        3. Single-use equipment
          1. Single-use equipment By Value
        4. Other Equipment
          1. Other Equipment By Value
      6. System and Software
        1. By Value
      7. Other Products
        1. By Value
    3. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. T-Cells
        1. By Value
      3. Stem Cells
        1. By Value
      4. Other Cells
        1. By Value
    4. By Cell Process
      1. Introduction
        1. Cell Process By Value
      2. Cell Processing
        1. By Value
      3. Cell Preservation, Distribution, and Handling
        1. By Value
      4. Process Monitoring and Quality Control
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Biopharmaceutical and Biotechnology companies
        1. By Value
      3. CRO’s and CMO’s
        1. By Value
      4. Research Institutes & Cell Banks
        1. By Value
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Media, Sera, and Reagents
        1. By Value
      3. Cell Engineering products
        1. By Value
      4. Cell Culture Vessels
        1. By Value
      5. Cell therapy Equipment
        1. By Value
        2. Cell Processing Equipment
          1. Cell Processing Equipment By Value
        3. Single-use equipment
          1. Single-use equipment By Value
        4. Other Equipment
          1. Other Equipment By Value
      6. System and Software
        1. By Value
      7. Other Products
        1. By Value
    3. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. T-Cells
        1. By Value
      3. Stem Cells
        1. By Value
      4. Other Cells
        1. By Value
    4. By Cell Process
      1. Introduction
        1. Cell Process By Value
      2. Cell Processing
        1. By Value
      3. Cell Preservation, Distribution, and Handling
        1. By Value
      4. Process Monitoring and Quality Control
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Biopharmaceutical and Biotechnology companies
        1. By Value
      3. CRO’s and CMO’s
        1. By Value
      4. Research Institutes & Cell Banks
        1. By Value
    6. U.S.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Media, Sera, and Reagents
          1. By Value
        3. Cell Engineering products
          1. By Value
        4. Cell Culture Vessels
          1. By Value
        5. Cell therapy Equipment
          1. By Value
          2. Cell Processing Equipment
            1. Cell Processing Equipment By Value
          3. Single-use equipment
            1. Single-use equipment By Value
          4. Other Equipment
            1. Other Equipment By Value
        6. System and Software
          1. By Value
        7. Other Products
          1. By Value
      2. By Cell Type
        1. Introduction
          1. Cell Type By Value
        2. T-Cells
          1. By Value
        3. Stem Cells
          1. By Value
        4. Other Cells
          1. By Value
      3. By Cell Process
        1. Introduction
          1. Cell Process By Value
        2. Cell Processing
          1. By Value
        3. Cell Preservation, Distribution, and Handling
          1. By Value
        4. Process Monitoring and Quality Control
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Biopharmaceutical and Biotechnology companies
          1. By Value
        3. CRO’s and CMO’s
          1. By Value
        4. Research Institutes & Cell Banks
          1. By Value
    7. Canada
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Media, Sera, and Reagents
        1. By Value
      3. Cell Engineering products
        1. By Value
      4. Cell Culture Vessels
        1. By Value
      5. Cell therapy Equipment
        1. By Value
        2. Cell Processing Equipment
          1. Cell Processing Equipment By Value
        3. Single-use equipment
          1. Single-use equipment By Value
        4. Other Equipment
          1. Other Equipment By Value
      6. System and Software
        1. By Value
      7. Other Products
        1. By Value
    3. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. T-Cells
        1. By Value
      3. Stem Cells
        1. By Value
      4. Other Cells
        1. By Value
    4. By Cell Process
      1. Introduction
        1. Cell Process By Value
      2. Cell Processing
        1. By Value
      3. Cell Preservation, Distribution, and Handling
        1. By Value
      4. Process Monitoring and Quality Control
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Biopharmaceutical and Biotechnology companies
        1. By Value
      3. CRO’s and CMO’s
        1. By Value
      4. Research Institutes & Cell Banks
        1. By Value
    6. U.K.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Media, Sera, and Reagents
          1. By Value
        3. Cell Engineering products
          1. By Value
        4. Cell Culture Vessels
          1. By Value
        5. Cell therapy Equipment
          1. By Value
          2. Cell Processing Equipment
            1. Cell Processing Equipment By Value
          3. Single-use equipment
            1. Single-use equipment By Value
          4. Other Equipment
            1. Other Equipment By Value
        6. System and Software
          1. By Value
        7. Other Products
          1. By Value
      2. By Cell Type
        1. Introduction
          1. Cell Type By Value
        2. T-Cells
          1. By Value
        3. Stem Cells
          1. By Value
        4. Other Cells
          1. By Value
      3. By Cell Process
        1. Introduction
          1. Cell Process By Value
        2. Cell Processing
          1. By Value
        3. Cell Preservation, Distribution, and Handling
          1. By Value
        4. Process Monitoring and Quality Control
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Biopharmaceutical and Biotechnology companies
          1. By Value
        3. CRO’s and CMO’s
          1. By Value
        4. Research Institutes & Cell Banks
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Media, Sera, and Reagents
        1. By Value
      3. Cell Engineering products
        1. By Value
      4. Cell Culture Vessels
        1. By Value
      5. Cell therapy Equipment
        1. By Value
        2. Cell Processing Equipment
          1. Cell Processing Equipment By Value
        3. Single-use equipment
          1. Single-use equipment By Value
        4. Other Equipment
          1. Other Equipment By Value
      6. System and Software
        1. By Value
      7. Other Products
        1. By Value
    3. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. T-Cells
        1. By Value
      3. Stem Cells
        1. By Value
      4. Other Cells
        1. By Value
    4. By Cell Process
      1. Introduction
        1. Cell Process By Value
      2. Cell Processing
        1. By Value
      3. Cell Preservation, Distribution, and Handling
        1. By Value
      4. Process Monitoring and Quality Control
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Biopharmaceutical and Biotechnology companies
        1. By Value
      3. CRO’s and CMO’s
        1. By Value
      4. Research Institutes & Cell Banks
        1. By Value
    6. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Media, Sera, and Reagents
          1. By Value
        3. Cell Engineering products
          1. By Value
        4. Cell Culture Vessels
          1. By Value
        5. Cell therapy Equipment
          1. By Value
          2. Cell Processing Equipment
            1. Cell Processing Equipment By Value
          3. Single-use equipment
            1. Single-use equipment By Value
          4. Other Equipment
            1. Other Equipment By Value
        6. System and Software
          1. By Value
        7. Other Products
          1. By Value
      2. By Cell Type
        1. Introduction
          1. Cell Type By Value
        2. T-Cells
          1. By Value
        3. Stem Cells
          1. By Value
        4. Other Cells
          1. By Value
      3. By Cell Process
        1. Introduction
          1. Cell Process By Value
        2. Cell Processing
          1. By Value
        3. Cell Preservation, Distribution, and Handling
          1. By Value
        4. Process Monitoring and Quality Control
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Biopharmaceutical and Biotechnology companies
          1. By Value
        3. CRO’s and CMO’s
          1. By Value
        4. Research Institutes & Cell Banks
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Singapore
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Media, Sera, and Reagents
        1. By Value
      3. Cell Engineering products
        1. By Value
      4. Cell Culture Vessels
        1. By Value
      5. Cell therapy Equipment
        1. By Value
        2. Cell Processing Equipment
          1. Cell Processing Equipment By Value
        3. Single-use equipment
          1. Single-use equipment By Value
        4. Other Equipment
          1. Other Equipment By Value
      6. System and Software
        1. By Value
      7. Other Products
        1. By Value
    3. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. T-Cells
        1. By Value
      3. Stem Cells
        1. By Value
      4. Other Cells
        1. By Value
    4. By Cell Process
      1. Introduction
        1. Cell Process By Value
      2. Cell Processing
        1. By Value
      3. Cell Preservation, Distribution, and Handling
        1. By Value
      4. Process Monitoring and Quality Control
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Biopharmaceutical and Biotechnology companies
        1. By Value
      3. CRO’s and CMO’s
        1. By Value
      4. Research Institutes & Cell Banks
        1. By Value
    6. UAE
      1. By Product
        1. Introduction
          1. Product By Value
        2. Media, Sera, and Reagents
          1. By Value
        3. Cell Engineering products
          1. By Value
        4. Cell Culture Vessels
          1. By Value
        5. Cell therapy Equipment
          1. By Value
          2. Cell Processing Equipment
            1. Cell Processing Equipment By Value
          3. Single-use equipment
            1. Single-use equipment By Value
          4. Other Equipment
            1. Other Equipment By Value
        6. System and Software
          1. By Value
        7. Other Products
          1. By Value
      2. By Cell Type
        1. Introduction
          1. Cell Type By Value
        2. T-Cells
          1. By Value
        3. Stem Cells
          1. By Value
        4. Other Cells
          1. By Value
      3. By Cell Process
        1. Introduction
          1. Cell Process By Value
        2. Cell Processing
          1. By Value
        3. Cell Preservation, Distribution, and Handling
          1. By Value
        4. Process Monitoring and Quality Control
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Biopharmaceutical and Biotechnology companies
          1. By Value
        3. CRO’s and CMO’s
          1. By Value
        4. Research Institutes & Cell Banks
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. The rest of MEA
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Media, Sera, and Reagents
        1. By Value
      3. Cell Engineering products
        1. By Value
      4. Cell Culture Vessels
        1. By Value
      5. Cell therapy Equipment
        1. By Value
        2. Cell Processing Equipment
          1. Cell Processing Equipment By Value
        3. Single-use equipment
          1. Single-use equipment By Value
        4. Other Equipment
          1. Other Equipment By Value
      6. System and Software
        1. By Value
      7. Other Products
        1. By Value
    3. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. T-Cells
        1. By Value
      3. Stem Cells
        1. By Value
      4. Other Cells
        1. By Value
    4. By Cell Process
      1. Introduction
        1. Cell Process By Value
      2. Cell Processing
        1. By Value
      3. Cell Preservation, Distribution, and Handling
        1. By Value
      4. Process Monitoring and Quality Control
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Biopharmaceutical and Biotechnology companies
        1. By Value
      3. CRO’s and CMO’s
        1. By Value
      4. Research Institutes & Cell Banks
        1. By Value
    6. Brazil
      1. By Product
        1. Introduction
          1. Product By Value
        2. Media, Sera, and Reagents
          1. By Value
        3. Cell Engineering products
          1. By Value
        4. Cell Culture Vessels
          1. By Value
        5. Cell therapy Equipment
          1. By Value
          2. Cell Processing Equipment
            1. Cell Processing Equipment By Value
          3. Single-use equipment
            1. Single-use equipment By Value
          4. Other Equipment
            1. Other Equipment By Value
        6. System and Software
          1. By Value
        7. Other Products
          1. By Value
      2. By Cell Type
        1. Introduction
          1. Cell Type By Value
        2. T-Cells
          1. By Value
        3. Stem Cells
          1. By Value
        4. Other Cells
          1. By Value
      3. By Cell Process
        1. Introduction
          1. Cell Process By Value
        2. Cell Processing
          1. By Value
        3. Cell Preservation, Distribution, and Handling
          1. By Value
        4. Process Monitoring and Quality Control
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Biopharmaceutical and Biotechnology companies
          1. By Value
        3. CRO’s and CMO’s
          1. By Value
        4. Research Institutes & Cell Banks
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Cell Therapy Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Gilead Sciences
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Novartis
    3. Vericel Corporation
    4. Smith Nephew
    5. Kite Pharma, Inc.
    6. Osiris Therapeutics
    7. Celgene Corporation
    8. Medipost Co., Ltd.
    9. Adaptimmune Therapeutics plc.
    10. NuVasive, Inc.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer
  • 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.

  • 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.



We are featured on :

OSZAR »